REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,055,332 | +55.9% | 451,700 | +39.0% | 0.24% | +46.6% |
| Q1 2023 | $29,549,000 | +134.3% | 325,000 | -2.1% | 0.16% | +117.3% |
| Q4 2022 | $12,612,680 | -17.7% | 332,000 | +342.7% | 0.08% | -27.2% |
| Q4 2019 | $15,332,000 | +4.9% | 75,000 | -58.8% | 0.10% | -6.4% |
| Q3 2019 | $14,618,000 | -80.6% | 182,060 | -77.2% | 0.11% | -77.6% |
| Q2 2019 | $75,480,000 | +17.7% | 800,000 | +6.7% | 0.49% | +1.9% |
| Q1 2019 | $64,103,000 | +63.2% | 750,000 | +7.1% | 0.48% | +67.4% |
| Q4 2018 | $39,270,000 | -28.7% | 700,000 | +3.9% | 0.29% | -11.4% |
| Q3 2018 | $55,065,000 | – | 673,500 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |